Women’s Health–Surging demand for female contraceptives

According to a recent report by Emergen Research, the global market for women’s health is anticipated to reach USD 24.48 billion by 2027. The demand for devices (intrauterine devices, vaginal rings, and implants) and medications (Prolia, Evista, Xgeva, Mirena, and Zometa, among others) for applications including contraception, postmenopausal osteoporosis, hormonal infertility, menopause, endometriosis, and polycystic ovary syndrome (PCOS), among others, is high in the women’s healthcare market.

In particular in developing nations, the availability of contraception and gynaecological testing has decreased, increasing the rate of unsafe abortions and unintended pregnancies. For instance, the BMC reports that the use of long- and short-acting reversible contraceptives and essential services for pregnancy care have both decreased by about 10% in low- and middle-income countries. In spite of the pandemic, all these factors caused market growth to slow down. Women are more prone to endometriosis, osteoporosis, osteoarthritis, and menstrual health issues, among other diseases.

Download PDF https://www.emergenresearch.com/request-sample/91

Market Size and Analysis:

Procedures, drugs, and surgical aids used to treat the various disorders affecting this population collectively are referred to as “women’s health.” These diseases span a range of medical specialties, including urology, nutrition, oncology, reproduction, menopause, and others. Enhancing women’s overall health and improving disease management are the two main objectives of women’s health. The efforts of numerous governments to increase public awareness of women’s health are intensifying. Some organisations, such as the World Health Organization (WHO) and the US Food and Drug Administration (FDA), are introducing new safety initiatives to improve women’s health.

Market Size: $9.51 billion in revenue in 2019, Market Growth: 12.5% CAGR, and Market Trends: Exploding demand for female contraceptives

The market for women’s health would experience growth over the forecast period as a result of increased investments in femtech, which would also benefit the industry’s players. In the coming years, the demand for new femtech products like wearable instruments for monitoring and controlling patients’ health is likely to increase. Companies producing menstruation-related and/or fertility-tracking mobile apps include Clue, Glow, DOT, Eve, and Cycles, among others.

Dynamics of the Women’s Health Market

. augmentation of chronic diseases

The primary factors anticipated to drive the growth of the women’s health market during the forecast period are the rising prevalence of chronic illnesses among women and the rising demand for contraceptives to prevent unintended pregnancies. In addition, the government is taking steps to slow down population growth and is putting more of an emphasis on product development.

.creation of novel medications

The development of new medicines specifically for women and the rise in the proportion of women over 60 who adopt unhealthy lifestyle habits are the two main factors driving the global market for women’s health. Women are prone to a variety of illnesses, such as osteoporosis, osteoarthritis, anemia, irregular menstrual cycles, depression, and obesity. Therefore, it is anticipated that the rise in illnesses in the coming years will spur market growth.

.rising illnesses related to stress

Along with a number of government initiatives to promote health awareness, it is also anticipated that rising rates of stress-related osteoarthritis, infertility, and other illnesses will fuel the growth of the women’s health industry in the region over the ensuing years.